CollaGenex Pharmaceuticals Inc. said Wednesday its rosacea treatment candidate incyclinide failed to meet its goal in a midstage study and said the program is being closed.
From: biz.yahoo.com
CollaGenex Drug Fails Midstage Study
Posted by Ruslan Abuzant at 7:15 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment